This inventor holds 1 USPTO granted patent. Top assignee: Biochem Pharma Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Sylvie Charron: Innovator in Integrin Inhibition
Introduction
Sylvie Charron is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit integrins. Her work is crucial for advancing therapeutic options in various medical applications.
Latest Patents
Charron holds a patent for "Thiophene integrin inhibitors." This invention comprises compounds that effectively inhibit integrins, specifically the αvβ3 and αvβ5 integrins. The compounds are characterized by a specific formula, which enhances their efficacy in medical treatments.
Career Highlights
Throughout her career, Sylvie Charron has demonstrated a strong commitment to innovation in biochemistry. Her research has led to advancements that could potentially improve patient outcomes in various health conditions.
Collaborations
Charron has collaborated with esteemed colleagues, including Denis Labrecque and Giorgio Attardo. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Sylvie Charron's contributions to integrin inhibition represent a significant advancement in biochemistry. Her innovative work continues to pave the way for future developments in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile